Tiotropium in asthma: what is the evidence and how does it fit in?

by David M.G. Halpin
Published 2016-01-01

Precision medicine in chronic obstructive pulmonary disease

by David M.G. Halpin, Peifang Wei
Published 2022-05-01

Systematic review of the effects of patient errors using inhaled delivery systems on clinical outcomes in COPD

by David M G Halpin, Donald A Mahler
Published 2024-04-01

Inhalation Devices

by Petra Moroni-Zentgraf, Omar S. Usmani, David M. G. Halpin
Published 2018-01-01

Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019

by David M.G. Halpin, Hilda J.I. de Jong, Victoria Carter, Derek Skinner, David Price
Published 2019-09-01

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

by David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha
Published 2021-02-01

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial

by Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin, Antonio Anzueto
Published 2018-10-01

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

by Klaus F. Rabe, David M. G. Halpin, MeiLan K. Han, Marc Miravitlles, Dave Singh, Lars Grönke, Florian Voß, Fernando J. Martinez
Published 2020-07-01

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design

by Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton
Published 2019-11-01

Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1

by David M. G. Halpin, Eli O. Meltzer, Wendelgard Pisternick-Ruf, Petra Moroni-Zentgraf, Michael Engel, Liliana Zaremba-Pechmann, Thomas Casale, J. Mark FitzGerald
Published 2019-07-01

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses

by David M.G. Halpin, Ruby Birk, Noushin Brealey, Gerard J. Criner, Mark T. Dransfield, Emma Hilton, David A. Lomas, Chang-Qing Zhu, David A. Lipson
Published 2018-05-01

Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis

by David M. G. Halpin, Eckard H. Hamelmann, Peter A. Frith, Petra M. Moroni-Zentgraf, Benjamin van Hecke, Anna Unseld, Huib A. M. Kerstjens, Stanley J. Szefler
Published 2020-03-01

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations

by David B. Price, Sinthia Bosnic-Anticevich, Ian D. Pavord, Nicolas Roche, David M. G. Halpin, Leif Bjermer, Omar S. Usmani, Guy Brusselle, Simon Wan Yau Ming, Sarang Rastogi
Published 2019-08-01

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospe...

by Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey, David M. G. Halpin
Published 2023-09-01

Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation...

by Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey, David M. G. Halpin
Published 2024-04-01

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice

by David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton
Published 2021-06-01

Blood eosinophil count predicts treatment failure and hospital readmission for COPD

by Marjan Kerkhof, Isha Chaudhry, Ian D. Pavord, Marc Miravitlles, Chin Kook Rhee, David M.G. Halpin, Omar S. Usmani, Rupert Jones, Janwillem Kocks, Marianna Alacqua, Tamsin Morris, Alan Kaplan, David B. Price
Published 2020-11-01

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post...

by Raj Sharma, Claus F Vogelmeier, Kieran J Rothnie, David M G Halpin, Alexandrosz Czira, Chris Compton, Afisi S Ismaila, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif
Published 2024-03-01

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial

by Mark T. Dransfield, Gerard J. Criner, David M. G. Halpin, MeiLan K. Han, Benjamin Hartley, Ravi Kalhan, Peter Lange, David A. Lipson, Fernando J. Martinez, Dawn Midwinter, Dave Singh, Robert Wise, Ken M. Kunisaki
Published 2022-09-01

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

by Jonathan Corren, Constance H. Katelaris, Mario Castro, Jorge F. Maspero, Marc Humbert, David M.G. Halpin, Arman Altincatal, Nami Pandit-Abid, Xavier Soler, Amr Radwan, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe
Published 2023-10-01